Recently, acquired CSF3R mutations (in particular the CSF3R T618I mutation) were described in a majority of patients diagnosed with CNL or atypical chronic myeloid leukemia (aCML) [2, 7]. The gene discussed is CSF3R; the disease is chronic neutrophilic leukemia.